Core Insights - Cytek Biosciences, a leader in spectral flow cytometry, is set to showcase its advanced solutions at two major industry events, emphasizing the growing demand for deeper cellular insights in cancer research and diagnostics [1][4] Company Overview - Cytek Biosciences specializes in high-resolution, high-content, and high-sensitivity cell analysis tools, utilizing its patented Full Spectrum Profiling™ (FSP) technology [8] - The company's FSP systems have been referenced in over 2,800 peer-reviewed publications, indicating widespread acceptance and application in the research community [2] Technology and Innovation - Cytek's Full Spectrum Profiling™ technology allows for the profiling of more than 40 markers in a single tube, significantly enhancing efficiency and reducing analysis time [7] - The integration of spectral flow cytometry with machine learning is being explored to simplify data analysis and reduce technician workload, as demonstrated in workshops at upcoming conferences [4][6] Industry Events - The European Society for Clinical Cell Analysis (ESCCA) 2025 Conference will take place from September 17 to September 20, 2025, in Montpellier, France, focusing on clinical applications in various fields [3] - The ICCS Annual Meeting & Course will be held from September 28 to September 30, 2025, in Philadelphia, bringing together professionals to advance knowledge in clinical cytometry [5] Leadership and Expertise - Dr. Wenbin Jiang, CEO of Cytek, highlighted the advantages of spectral flow cytometry in enabling laboratories to achieve more with less, thereby allowing scientists to focus on high-skill tasks [7] - Workshops led by experts like Dr. Joseph C. Lownik and Dr. Paul K. Wallace will present innovative approaches to using spectral flow cytometry for accurate diagnosis of leukemia and lymphoma [4][6]

Core Insights - Cytek Biosciences, Inc. has launched the Cytek Aurora™ Evo system, a new full spectrum flow cytometer that enhances the capabilities of its predecessor, the Cytek Aurora system [1][3][5] Product Features and Innovations - The Cytek Aurora Evo system builds on the success of the original Aurora system, maintaining its reliability while introducing high-throughput and automation capabilities to meet modern research demands [3][4] - The system utilizes Cytek's Full Spectrum Profiling™ (FSP) technology, allowing for large multicolor experiments without compromising data quality and providing assay flexibility [3][4] - Key features include improved sample throughput, automated instrument maintenance, and data harmonization, which empower researchers to accelerate discoveries [3][11] - The system can acquire samples at rates up to 200 µL/min, effectively doubling the speed of sample acquisition compared to previous models [11] Market Position and Impact - Cytek's innovative approach in spectral flow cytometry has positioned the company as a leader in the field, with over 2,600 peer-reviewed publications citing its FSP technology [2][4] - The new Aurora Evo system is expected to meet the increasing demand for high-performance and flexible cell analysis tools, further driving the adoption of spectral flow cytometry [4][5]